Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor to Present at Upcoming Investor Conferences By: Xencor, Inc. via Business Wire November 10, 2022 at 16:01 PM EST Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: Jefferies London Healthcare Conference Date: Tuesday, November 15, 2022 Presentation Time: 8:00 a.m. GMT / 12:00 a.m. PST Location: London Piper Sandler 34th Annual Healthcare Conference Date: Tuesday, November 29, 2022 Presentation Time: 12:30 p.m. EST / 9:30 a.m. PST Location: New York Live webcasts of these presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations. About Xencor Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005834/en/Contacts Charles Liles cliles@xencor.com 626-737-8118 Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Xencor to Present at Upcoming Investor Conferences By: Xencor, Inc. via Business Wire November 10, 2022 at 16:01 PM EST Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: Jefferies London Healthcare Conference Date: Tuesday, November 15, 2022 Presentation Time: 8:00 a.m. GMT / 12:00 a.m. PST Location: London Piper Sandler 34th Annual Healthcare Conference Date: Tuesday, November 29, 2022 Presentation Time: 12:30 p.m. EST / 9:30 a.m. PST Location: New York Live webcasts of these presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations. About Xencor Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005834/en/Contacts Charles Liles cliles@xencor.com 626-737-8118
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that company management will participate at two upcoming investor conferences: Jefferies London Healthcare Conference Date: Tuesday, November 15, 2022 Presentation Time: 8:00 a.m. GMT / 12:00 a.m. PST Location: London Piper Sandler 34th Annual Healthcare Conference Date: Tuesday, November 29, 2022 Presentation Time: 12:30 p.m. EST / 9:30 a.m. PST Location: New York Live webcasts of these presentations will be available under "Events & Presentations" in the Investors section of the Company's website located at www.xencor.com. Replays of the events will be available on the Xencor website for at least 30 days following the presentations. About Xencor Xencor is a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases. More than 20 candidates engineered with Xencor's XmAb® technology are in clinical development, and three XmAb medicines are marketed by partners. Xencor's XmAb engineering technology enables small changes to a protein's structure that result in new mechanisms of therapeutic action. For more information, please visit www.xencor.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20221110005834/en/